$HKPD

$2.19 +$0.19 (9.5%) Close

$HKPD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 16.3M shares outstanding

Who owns HKPD?

By type of holder

Institutions 1.5% Insiders 0.0% Everyone else 98.5%

Concentration Top 7 holders own 45.2%

Liying Wang 43.7% · StoneX Group Inc. 0.6%

Institutional ownership

1.5%

+1.1 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+182.9K

by institutions in Q2 2026

New / sold out

3 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

StoneX Group Inc. +62.9K
Jane Street Group, LLC NEW +49.1K

Biggest sellers in Q2 2026

Two Sigma Investments, LP SOLD OUT −10.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Cellyan Biotechnology Co Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Cellyan Biotechnology Co Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

164.0%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting HKPD on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SG StoneX Group Inc.	102.3K	0.63%	+62.9K (+159.7%)	Q4 '25	0.0%
Shares held by quarter Peak holding102.3K (Q2'26) Change over 8 quarters+102.3K Share of the company0.630% StoneX Group Inc.'s full portfolio →
JS Jane Street Group, LLC	49.1K	0.30%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding49.1K (Q2'26) Change over 8 quarters+49.1K Share of the company0.300% Jane Street Group, LLC's full portfolio →

StoneX Group Inc.

102.3K

% of company

0.63%

Change vs last qtr

+62.9K (+159.7%)

Held since

Q4 '25

Jane Street Group, LLC

49.1K

% of company

0.30%

Change vs last qtr

NEW

Held since

Q2 '26

5 more super investors behind a free account

See every manager holding Cellyan Biotechnology Co Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting HKPD on Form N-PORT; together they hold 0.0% of the company

No fund reports holding HKPD yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LW Liying Wang 5%+ holder 13D · 65.0%	7.2M	43.73%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company43.730% Disclosed stake13D · 65.0% View the 13D/G filing →

Liying Wang

5%+ holder13D · 65.0%

7.2M

% of company

43.73%

Change vs last qtr

—

Held since

—

Comments